A non-invasive ear clip could replace risky brain surgeries for patients recovering from aneurysms.

Surviving a ruptured brain aneurysm is only the first battle. For up to 70 percent of survivors, the real danger arrives days later when brain arteries suddenly constrict.
This condition, called cerebral vasospasm, starves the brain of oxygen and causes secondary strokes. Currently, doctors have no approved devices to prevent this lethal complication. They must rely on oral medications or invasive, high-risk rescue surgeries.

A different pathway

A new device called V-Link takes an unexpected route through the outer ear. By sending low-energy electrical pulses to the vagus nerve, it targets the inflammatory response that drives these spasms.
Early data shows the device cut cerebral vasospasm by more than 40 percent.
The FDA just granted the system its breakthrough device designation. This regulatory fast-track will speed up development, but the technology still faces major hurdles.

The clinical hurdle

Early trials are promising, but they are small. The developer, Aurenar, must now prove these results in larger, pivotal clinical trials.
If the data holds, it shifts how we approach acute brain injuries. It moves the treatment paradigm away from risky skull-based interventions toward simple, external nerve stimulation.
It also suggests that the autonomic nervous system is a viable volume dial for brain inflammation. If we can control vasospasms through the ear, we might target other neuroinflammatory conditions the same way.
The medical community has long struggled to protect the brain after a bleed. Treating the brain through the ear sounds unusual, but it may soon become the standard of care.